http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015029530-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef8d8a82fd7380682fc0828e58b5f89e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J3-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
filingDate 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c828430d2961bd5cb9d919fa21181c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1dda2722ac67c16cf827c9c349aa213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a49498f6662e0527c7a69a5628680979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dbcfb45a161b78379bf18006b48d7d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd629a69a07c22139a8fe8903cba1809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c70a6f093001c4d87f9d16b537eef1e
publicationDate 2019-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015029530-A8
titleOfInvention methods for treating inflammatory conditions using s- [4- (3-fluoro-3-methylbutyryloxy) but-2-ynyl] 6 alpha, 9 alpha difluoro-17 alpha (furan-2-yl) carbonyloxy 11β-hydroxy-16β-alpha-methyl-3-oxoandrosta-1,4-diene-17β-beta-carbothioate.
abstract methods for the treatment of inflammatory conditions using s- (4- (3-fluoro-3-methylbutyryloxy) but-2-ynyl] 6a, 9a- difluoro-17a- (furan-2-yl) carbonyloxy-11fa-hydroxy- 16 α-methyl-3-oxoandrosta-1,4-diene-17fi-carbothioate, the present invention relates to methods of treating inflammatory conditions using s- [4- (3-fluoro-3-methylbutyryloxy) -but- 2-inyl] 6a, 9a-difluoro-17a- (furan-2-yl) carbonyloxy-llp-hydroxy-16a-methyl-3-oxoandrosta-1,4-diene-17f3.-carbothioate (compound of formula i), a new anti-inflammatory compound from the androstane series and its preparation processes.
priorityDate 2013-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393638

Total number of triples: 27.